USP To Explore Imprint Coding For Solid Dosage Drugs, Supplements
This article was originally published in The Tan Sheet
Executive Summary
The United States Pharmocopeia voted to approve a resolution to consider the advisability of developing standardized imprint coding for all solid oral dosage form drugs and dietary supplements at USP's recent quinquennial meeting in Washington, D.C.